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Abstract  
Nicotinic acetylcholine receptors (nAChRs) are expressed throughout the central nervous 
system, including on neuron populations that control breathing. The specific locations of 
nAChRs on respiratory related neurons are relatively unknown and their presence on phrenic 
motor neurons (PMNs) could indicate a point at which developmental nicotine exposure may 
impact breathing. We hypothesize that application of nicotine to the PMNs will elicit changes in 
amplitude and area of respiratory motor bursting recorded from cervical 3-5 ventral roots due to 
the presence of nAChRs on PMNs. A brainstem spinal cord split-bath preparation was used to 
separately perfuse brainstem and spinal cord chambers with artificial cerebrospinal fluid (aCSF), 
and nicotinic aCSF was added to the spinal cord chamber. Burst amplitude and area under the 
curve were measured at baseline and during application of three different nicotine concentrations 
(400nM, 4M, 40M). Our results show that while 400nM nicotinic aCSF did not significantly 
affect the amplitude or area of bursts, both 4M and 40  nicotinic aCSF caused an initial 
increase in amplitude and area of the bursts, indicating nAChR activation, followed by a 
decrease in these parameters, indicating nAChR desensitization. These findings indicate the 
presence of nAChR on PMNs or neurons that synapse with PMNs. 
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Introduction:  
The respiratory control system is complex automatic system in the body that is powered 
by the brainstem. There are several factors that can create problems in the respiratory control 
system in both adults and babies, one in particular is smoking. Smoking during pregnancy results 
in respiratory issues in young children, especially babies. About half a million newborns born to 
smoking mothers each year and those who were exposed to nicotine in utero typically suffer 
from cardiovascular and respiratory issues or die from Sudden Infant Death Syndrome (SIDS).  
Sudden infant death syndrome is the unexplained death of a seemingly healthy baby 
(Mayo Clinic). It usually happens during 
sleep to babies that are less than a year 
old (Mayo Clinic). Approximately 2,500 
babies die of SIDS each year in the U.S. 
and it is currently the third leading cause 
of infant mortality (Illinois Department 
of Public Health). One possible 
explanation for SIDS could be defects in 
the portion of an infant's brainstem that 
controls breathing.  One reason for these 
defects could be brought on by 
developmental nicotine exposure.  
Nicotine Acetylcholine Receptors 
(nAChRs) are present ubiquitously 
throughout the central nervous system 
including brainstem and spinal cord Figure 1: Nicotine Acetylcholine Receptor 
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regions involved in the control of breathing. (Shao and Feldman 2009) However, their specific 
locations in these regions are still relatively unknown. nAChRs are seven transmembrane domain 
protein receptors that bind either the neurotransmitter Acetylcholine or the addictive chemical 
nicotine. (Albuquerque 2009) Once acetylcholine or nicotine bind to the receptor a 
conformational change occurs allowing for an influx of ions, typically sodium. nAChRs 
activation can modulate respiratory pattern and these receptors mediate the effects of nicotine 
from tobacco smoke and e-cigarette usage. (Shao and Feldman 2009) An activation of nAChRs 
always causes depolarization, but their presence on both excitatory and inhibitory neurons can 
lead to an array of complex effects on physiology. (Albuquerque 2009) 
The phrenic nerve innervates the diaphragm controlling its contraction and relaxation. 
The diaphragm is the muscle necessary for breathing as it is responsible for the movement of the 
thorax and lungs. The phrenic nerve is made up of the C3-C5 nerves, these nerves also go to 
other parts of the body such as the arm. Therefore, the activation of the phrenic motor neurons 
greatly effects respiratory activity, so if nAChR are present on phrenic motor neurons they can 
alter the activity when nicotine is introduced to the system. nAChRs are important for the 
modulation of fast-synaptic transmission, and if they are located on phrenic motors neurons 
(PMNs), or on other neurons that synapse with the PMNs, then their activation may impact 
neural output to the diaphragm. Thus, determining whether or not there are nAChR on phrenic 
motor neurons could indicate another way that nicotine can affect the respiratory system of an 
infant born to a smoking mother. 
 
 
Materials and Methods: 
Animals: Thirty neonatal rats (6.50-15g) of either sex were used, ranging from postnatal 
day 1-5 (P1-P5). Pups were derived from litters born to dams who drank saccharin water (1g 
saccharin/100mL tap water) throughout gestation and during the first week after spontaneous 
vaginal delivery. These dams were a part of a control group (saccharin water) for a larger 
experiment investigating the effects of developmental nicotine exposure, where nicotine was 
delivered to pregnant dams through drinking water using saccharin for palatability (nicotine + 
saccharin water). All data were obtained from experiments approved by the Institutional Animal 
Care and Use Committee at the University of Arizona. 
Spinal Cord and Brainstem Extraction. P1-P5 neonatal rats were anesthetized with 
hypothermia. Once anesthetized, the brainstem and spinal cord were removed and placed in cold 
oxygenated (O2, 95%; CO2, 5%) artificial cerebrospinal fluid solution (aCSF) consisting of (in 
mM): 125 NaCl, 24 NaHCO3, 1 MgCl2, 2.5 KCl, 1 CaCl2, and 10 D-glucose with a pH of 7.3-
7.45 and osmolarity of 300-320 mOSM. 
Electrophysiology. Once extracted, the brainstem-spinal cord preparation was placed in a 
split-bath recording chamber, which has a partition separating the brainstem and spinal cord 
portions of tissue so that the two chambers (rostral and caudal) can be perfused separately. Each 
chamber was filled with oxygenated aCSF with a constant drip flow. Glass micro pipettes 
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containing a silver wire electrode were 
filled with aCSF and suction was used to 
record from cervical ventral roots 3-5 (C3-
C5) which make up the phrenic nerve that 
innervates the diaphragm. From these 
ventral roots, spontaneous respiratory motor 
bursting can be recorded. Baseline 
amplitude of these respiratory bursts was 
recorded for 25 minutes with regular aCSF 
perfusing through both chambers. After the 
25-minute baseline period, nicotinic aCSF 
was perfused into the caudal (spinal cord) 
chamber only. Spontaneous bursting was 
recorded throughout the twenty-minute 
exposure to nicotinic aCSF, and throughout a 25-minute period of “wash-out” with regular 
aCSF. Amplitude changes are closely monitored to determine the possible presence or absence of 
nAChRs. To record the bursting activity, a Grass Instrument Amplifier was used that filtered the 
signal with a bandpass ranging from 30-1000 Hz. 
Nicotine Concentrations: Three sets of 
experiments were performed using three different 
concentrations of nicotine: 400nM, 4M, and 40M. 
Nicotinic aCSF was prepared daily by adding 50L, 
500L or 5mL of stock nicotine solution (1mg/1mL 
Nicotine Bitartrate Dihydrate, M.W. 498.44/mol), 
respectively, to 250mL of oxygenated aCSF. To 
equilibrate, the nicotinic aCSF is oxygenated for about 
10 minutes prior to being used for each experiment. 
Data Analysis and Statistics: Three Spike2 
Software (CED, Cambridge, UK) filter settings were 
used to filter bursting activity obtained from the Grass 
Instrument Amplifier: DC remove, rectify, and smooth 
with a 0.1sec time constant. The amplitude and area for 
each individual burst for both the 400nM and 4M 
concentrations were calculated using a custom software 
program written with Spike2 Software. Figure 3 
shows how the data analysis was done using this 
software.  For the 40M data, a different analysis 
approach had to be used due to the amount of evoked 
tonic activity. The peak amplitude of tonic activity 
was compared to the baseline to determine the 
percentage change from baseline, shown in Figure 4. 
 
Figure 3: Analysis method used to 
determine amplitude and area taken from 
each individual burst of the 400nM and 
4M doses. (Jaiswal, S. J., Pilarski, J.Q., 
Harrison, C.M., Fregosi, R.F.) 
Figure 2: Brainstem-spinal cord preparation in 
split-bath recording chamber with a partition 
separating the brainstem and spinal cord.  
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Note that the baseline was considered 100%. One sample t-tests were used to determine if drug-
induced changes were significant, using P<0.05 as the threshold for significance (GraphPad 
Prism 6 was used for all statistical analyses). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Data analysis method used for 40M concentration raw data. Due to the large 
increases in tonic activity, the customized Spike2 program could not analyze the area under the 
curve nor the amplitude of each individual burst for this data set. The figure shows from which 
point baseline and the peak amplitude were measured from and what was considered to be the 
percentage change from baseline. 
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Results:  
400nM Nicotinic CSF (Low dose) 
First, to test the effects of a low-dose of nicotine on respiratory burst amplitude, area and 
average amplitude, we perfused 400nM nicotinic aCSF into the spinal cord chamber of the split 
bath (caudal chamber). Figure 5 shows a representative recording from the low-dose nicotinic 
aCSF group, where the bottom trace is the raw record and top trace is the integrated and rectified 
record used for analysis. Baseline amplitude was recorded for 25 minutes, after which 400nM 
nicotinic aCSF was added to the spinal cord chamber of the split bath for 20 minutes. At this 
dose, the raw data showed a slight increase or no increase in amplitude and area during the nCSF 
phase. Upon washout, the amplitude and area decreased below baseline values or remained 
unchanged. Burst amplitude, area, and average amplitude were averaged over the last 20 minutes 
of the baseline period, and over the entirety of nicotine exposure and washout. Overall, the 
statistical analysis showed no significant change from baseline in either the nCSF phase or in the 
wash-out period. There was also no change in tonic activity throughout the 400nM dose 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
nCSF  Washout  
Figure 5: Representative trace of raw record (bottom) and the rectified and smoothed 
record (Top) used for analysis. Arrows indicate the start and end of perfusion of low dose 
nicotinic aCSF (400nM) into the spinal cord chamber of the split bath. 
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Figure 6: Changes in burst amplitude, 
area, and average amplitude recorded 
during 400nM nicotinic aCSF application 
(closed circles) and after washout (open 
squares). Values are normalized to 
baseline. Each point represents a single 
experiment and horizontal lines indicate 
group mean ± SD. 
A 
C 
B 
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4 M Nicotinic CSF (Middle dose) 
Next, we tested a moderate dose of nicotine by perfusing the spinal cord chamber of the 
split bath with 4M Nicotinic CSF. Figure 6 shows a representative recording from the 4M 
dose nicotinic aCSF group. With bath application of 4M nicotinic CSF (nCSF) there were a 
statistically significant increases in amplitude, area, and average amplitude. As seen in Figure 7, 
the amplitude starts to increase at about 4-5 minutes after the introduction of the nicotinic CSF. 
One or two minutes after the initial increase, there is a notable decrease in burst amplitude after 
the initial peak, and amplitude returns to baseline by the end of the nCSF wash-in phase. We 
hypothesize that this decrease indicates desensitization of nAChRs. After 20 minutes in nCSF, 
washout began with regular aCSF began. During washout amplitude and area remained near 
baseline values. The statistical analysis showed a 20% increase from baseline amplitude with 
nCSF and a 4.9% increase compared to baseline during washout. The percentage increase of the 
washout meant that the amplitude dropped significantly after the nCSF phase but remained 4.9% 
above the baseline. A similar pattern was observed in both the area and average amplitude 
analysis. Area increased by 34% compared to baseline during nCSF phase and remained 
increased by 8% from baseline after washout (a 26% decrease from nCSF phase). The average 
amplitude increased by 17% from baseline during the nCSF phase and remained 4.7% increased 
from baseline during the washout (a 12.3% decrease from the nCSF).  
 
 
 
 
 
 
Washout  nCSF  
Figure 7: Figure 9: Representative trace of raw record (bottom) and the rectified and 
smoothed record (Top) used for analysis. Arrows indicate the start and end of perfusion 
of middle dose nicotinic aCSF (4M) into the spinal cord chamber of the split bath. 
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Figure 8: Changes in burst amplitude, 
area, and average amplitude recorded 
during 4M nicotinic aCSF application 
(closed circles) and after washout (open 
squares). Values are normalized to 
baseline. Each point represents a single 
experiment and horizontal lines indicate 
group mean ± SD. 
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40M Nicotinic CSF (High dose) 
Lastly, we tested a high dose of nicotine by perfusing the spinal cord chamber of the split 
bath with 40 M nicotinic CSF. A representative recording is shown in Figure 9. The application 
of 40M nCSF caused a robust increase in amplitude, area and average amplitude. However, the 
exact percent increases of the area and amplitude were unable to be analyzed due to a concurrent 
increase in tonic activity. Instead, the percent increase from baseline to the peak of the tonic 
activity was measured. About three to four minutes after the nCSF is applied, there is a sharp 
increase in tonic activity. This is similar to the moderate dose of 4M nCSF, however, the 
increase begins sooner with the higher dose. Figure 10A shows the average data for this group. 
Tonic activity increased 200%-800% from baseline. The total duration of the elevated tonic 
activity was 8 minutes on average, as shown in Figure 10B. Upon washout, the tonic activity 
decreased back to baseline about 5-6 minutes after the peak, once again indicating 
desensitization of the receptors.  
 
 
 
 
 
 
nCSF  Washout  
Figure 9: Representative trace of raw record (bottom) and the rectified and smoothed 
record (Top) used for analysis. Arrows indicate the start and end of perfusion of high 
dose nicotinic aCSF (40M) into the spinal cord chamber of the split bath. 
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Figure 10: Percentage change of tonic activity caused by application of 40M nCSF to the spinal 
cord perfusion chamber (Panel A). The duration of tonic activity is presented in Panel B. 
A 
B 
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Discussion 
The main findings of these experiments showed that nicotine does affect respiratory burst 
activity when applied to the spinal cord. Additionally, we found evidence that nAChRs 
desensitize after activation and these effects are highly dependent on nicotine dosage. Below, the 
significance of these findings and future directions are discussed. 
Nicotine application alters respiratory burst amplitude. The increases in amplitude 
observed in these experiments, specifically those observed in the 4M and 40M, indicate that 
nAChRs are likely present somewhere along or near the phrenic motor neurons. Additionally, 
there was a clear dose response to nicotine application, the higher the dose the greater the 
increase in burst amplitude from 
baseline. These results indicate that 
nAChRs are present either on the 
phrenic motor neurons or on 
glutamatergic neurons that synapse 
onto phrenic motor neurons, as shown 
in Figure 11. If this were the case, 
activation of the nAChRs on 
glutamatergic neurons would trigger a 
release of the excitatory 
neurotransmitter glutamate onto PMNs, 
which in turn would cause increased 
firing of PMNs. 
A second observation from 
these experiments is that after the 
initial increase in burst amplitude 
following middle or high dose nicotine, 
there is a gradual decrease in amplitude. 
This decrease occurred despite the 
continued presence of nicotine in the 
chamber. A known characteristic of 
nAChRs is that they can exhibit rapid 
desensitization. Therefore, we hypothesize that the decrease in amplitude and area seen in these 
experiments is likely due to nAChR desensitization. This further indicates the presence of these 
receptors on or near PMNs. 
Future directions. Further research can help determine whether the results of these 
experiments are due to activation of nAChRs on PMNs or activation of nAChRs on 
glutamatergic neurons that synapsed onto PMNs. The possibility of the nAChR being on 
glutamatergic neurons could be eliminated by blocking glutamate or by using a glutamate 
antagonist.  
nAChRs are known to desensitize due to chronic nicotine exposure and now that we 
know that nAChRs are present, an important next step is to determine how they are affected by 
developmental nicotine exposure and whether this impairs breathing in DNE animals. Therefore, 
it is important to repeat these experiments using brainstem spinal-cord preparations obtained 
from DNE neonates to test the hypothesis that DNE causes chronic desensitization of nAChRs 
on or near phrenic motor neurons. If this hypothesis is correct, this chronic desensitization would 
be observed as a smaller increase in burst amplitude, area, and tonic activity, and potentially a 
Figure 11: Shows a Glutamatergic Neuron with 
nAChRs synapsing onto a Phrenic Motor Neuron. 
This is a probable case, if the detected nAChRs are 
not actually located on the Phrenic Motor Neurons 
themselves. 
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more rapid desensitization phase in response to nCSF application. These results could mean a 
less effective respiratory control system, whereby the animals have a harder time responding to a 
respiratory challenge. This could possibly translate to a contributing factor that causes SIDS.  
Furthermore, the type and subtype of nAChRs can also be determined by adding type-
specific antagonists to the caudal chamber during the nicotinic aCSF phase. Identifying the 
specific type and subtype of nAChRs on the PMNs could potentially help in the development of 
target treatments or drugs that could increase the receptor’s desensitization threshold, help 
reopen desensitized receptors or lengthen activity period before they become fully desensitized.  
 
 
Acknowledgements: 
Thank you to everyone in the Fregosi lab for all their guidance: Emily Flanigan, Dr. Lila B. 
Wollman, Seres Cross, and especially Dr. Ralph F. Fregosi for allowing me to complete my 
honors thesis in his lab. 
 
 
References 
Albuquerque, E., Pereira, E.F.R., Alkondon. M., Rogers, S.W., “Mammalian Nicotinic 
Acetylcholine Receptors: From Structure to Function.” Physiological Reviews, vol. 89, no.  
1, 2009, pp. 73–120., doi:10.1152/physrev.00015.2008. 
Jaiswal, S. J., Pilarski, J.Q., Harrison, C.M., Fregosi, R.F., “Developmental Nicotine Exposure 
Alters AMPA Neurotransmission in the Hypoglossal Motor Nucleus and Pre-Botzinger 
Complex of Neonatal Rats.” Journal of Neuroscience, vol. 33, no. 6, 2013, pp. 2616–
2625., doi:10.1523/jneurosci.3711-12.2013. 
“Sudden Infant Death Syndrome and Infant Mortality.” Illinois Department of Public Health, 
www.idph.state.il.us/sids/sids_factsheet.htm. 
 “Sudden Infant Death Syndrome (SIDS).” Mayo Clinic, Mayo Foundation for Medical 
Education and Research, 13 Nov. 2018, www.mayoclinic.org/diseases-conditions/sudden-
infant-death-syndrome/symptoms-causes/syc-20352800. 
Pilarski, J.Q., Wakefield, H.E., Fuglevand, A.J., Levine, R.B., Fregosi, R.F., “Increased 
Nicotinic Receptor Desensitization in Hypoglossal Motor Neurons Following Chronic 
Developmental Nicotine Exposure.” Journal of Neurophysiology, American Physiological 
Society, Jan. 2012, www.ncbi.nlm.nih.gov/pmc/articles/PMC3349681/. 
Shao, X.M., Feldman. J.L., “Central Cholinergic Regulation of Respiration: Nicotinic 
Receptors.” Acta Pharmacologica Sinica, Nature Publishing Group, June 2009, 
www.ncbi.nlm.nih.gov/pmc/articles/PMC4002383/. 
Wollman, L.B., Haggerty, J., Pilarski, J.Q., Levine, R.B., Fregosi, R.F., “Developmental 
Nicotine Exposure Alters Cholinergic Control of Respiratory Frequency in Neonatal Rats.” 
Developmental Neurobiology, vol. 76, no. 10, 2016, pp. 1138–1149., 
doi:10.1002/dneu.22380. 
